SBL
Sargent Bickham Lagudis’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $7.28K | Buy |
179
+50
| +39% | +$2.03K | ﹤0.01% | 764 |
|
|
2022
Q3 | $8K | Hold |
129
| – | – | ﹤0.01% | 719 |
|
|
2022
Q2 | $8K | Hold |
129
| – | – | ﹤0.01% | 724 |
|
|
2022
Q1 | $8K | Hold |
129
| – | – | ﹤0.01% | 738 |
|
|
2021
Q4 | $10K | Buy |
129
+97
| +303% | +$7.52K | ﹤0.01% | 708 |
|
|
2021
Q3 | $4K | Hold |
32
| – | – | ﹤0.01% | 826 |
|
|
2021
Q2 | $5K | Hold |
32
| – | – | ﹤0.01% | 795 |
|
|
2021
Q1 | $4K | Hold |
32
| – | – | ﹤0.01% | 810 |
|
|
2020
Q4 | $5K | Hold |
32
| – | – | ﹤0.01% | 733 |
|
|
2020
Q3 | $3K | Hold |
32
| – | – | ﹤0.01% | 696 |
|
|
2020
Q2 | $2K | Hold |
32
| – | – | ﹤0.01% | 705 |
|
|
2020
Q1 | $1K | Hold |
32
| – | – | ﹤0.01% | 733 |
|
|
2019
Q4 | $2K | Hold |
32
| – | – | ﹤0.01% | 766 |
|
|
2019
Q3 | $1K | Hold |
32
| – | – | ﹤0.01% | 691 |
|
|
2019
Q2 | $2K | Hold |
32
| – | – | ﹤0.01% | 711 |
|
|
2019
Q1 | $1K | Hold |
32
| – | – | ﹤0.01% | 776 |
|
|
2018
Q4 | $1K | Hold |
32
| – | – | ﹤0.01% | 730 |
|
|
2018
Q3 | $1K | Hold |
32
| – | – | ﹤0.01% | 742 |
|
|
2018
Q2 | $2K | Buy |
+32
| New | +$2K | ﹤0.01% | 718 |
|